
119. The Moulds: Aspergillus part 2, invasive and chronic disease
ID:IOTS - Infectious Disease Insight Of Two Specialists
00:00
Future Treatments: New Oral and Inhaled Drugs
Darius highlights lorafim, inhaled opalconazole, ibrexafungerp and other novel antifungals in trials.
Play episode from 29:57
Transcript


